$ALR (Alere Inc.)

$ALR {{ '2016-08-10T10:53:33+0000' | timeago}} • Announcement

Diagnostic device provider $ALR said it has achieved In-Vitro Diagnostic (IVD) CE marking in Europe for its new Alere Reader, a diagnostic analyzer that can be used in both point-of-care and lab settings. Additional assays for detection of respiratory and healthcare associated infections will be added to the Alere Reader menu over next 6-12 months.

$DGX {{ '2017-10-19T14:18:39+0000' | timeago}} • Infographic

$DGX Quest Diagnostics Incorporated Earnings AlphaGraphic: Q3 2017 Highlights

$DGX {{ '2017-10-18T21:05:30+0000' | timeago}} • Announcement

Medical diagnostic company $DGX has agreed to acquire Cleveland HeartLab from equity investors. The company intends to set up a national center of excellence in diagnostic information services at Cleveland HeartLab's laboratory. The all-equity transaction is expected to close in 4Q17. The financial details of the deal were not disclosed.

$ABBV {{ '2017-10-18T16:05:30+0000' | timeago}} • Announcement

$ABBV and Harpoon Therapeutics, a biotechnology company developing novel T-cell recruiting biologic therapies, announced that they have entered an immuno-oncology research collaboration.

$UNH {{ '2017-10-18T15:11:12+0000' | timeago}} • Webcast

$UNH's health services business Optum seems to be on a roll. Optum's third quarter revenues eclipsed 8.4% to $23Bil, which is nearly half of $UNH’s total revenues. All business segments of Optum have generated double-digit earnings growth in 3Q. OptumHealth now directly reaches 90MM US consumers, which is an increase of 9MM vs. last year.

$UNH {{ '2017-10-17T19:30:35+0000' | timeago}} • Announcement

$UNH is the first firm amongst its peers to report earnings every quarter. For the first time in its history, it is on track to cross revenues of $200Bil in 2017. 3Q revenues jumped 9% to $50.3Bil. $UNH's withdrawal from ACA individual insurance markets, along with a health insurance tax deferral, reduced revenues by $1.6Bil and growth rate by 4%.

$UNH {{ '2017-10-17T17:16:02+0000' | timeago}} • Announcement

$UNH reported 26% jump in its profits aided by strong growth in its Optum business. This is the first quarter the health insurer is reporting results under the helm of new CEO Dave Wichmann, who replaced Steve Hemsley in September. The company also raised its outlook for 2017. It now expects GAAP EPS to touch $9.45 and adjusted EPS to reach $10.

$MYL {{ '2017-10-17T16:40:23+0000' | timeago}} • Announcement

$MYL announced that the United States District Court for the Eastern District of Texas issued a decision finding all asserted claims of the patents relating to Restasis invalid. The Court recognized that $AGN's patent protection for Restasis ended in 2014.

$AMGN {{ '2017-10-17T14:34:06+0000' | timeago}} • Announcement

$AMGN has entered into a neuroscience research collaboration with Boston Children's Hospital, which aims at identifying novel pain targets based on human genetic analyses. The one-year collaboration will focus on patients with genetic anomalies of pain sensitivity.

$UNH {{ '2017-10-17T11:55:37+0000' | timeago}} • Infographic

$UNH UnitedHealth Earnings AlphaGraphics: Q3 2017 Highlights

$AGN {{ '2017-10-16T21:26:34+0000' | timeago}} • Announcement

Drugmaker $AGN gets an adverse effect from the U.S. District Court for the Eastern District of Texas. The judge invalidated Allergan's Restasis patent deal, which was signed with the Mohawk Tribe in the last month. Allergan plans to appeal the ruling. Restasis, a dry-eye treatment drug,  generated $1.5Bil of revenues for Allergan in 2016.

$MASI {{ '2017-10-16T21:02:15+0000' | timeago}} • Announcement

$MASI announced that the bankruptcy court in San Diego has issued final judgment holding that Sotera Wireless Employees misappropriated Masimo trade secrets. The misappropriation stems from two former Masimo employees, James Welch and David Hunt, copying thousands of confidential Masimo documents and using Masimo’s trade secrets to benefit Sotera.

$XRAY {{ '2017-10-16T12:23:03+0000' | timeago}} • Announcement

$XRAY appointed two new leadership team members effective immediately. Nick Alexos joins the company as EVP, Chief Administrative Officer, reporting to Mark Thierer, Interim CEO. Additionally, Keith Ebling joins as EVP, General Counsel & Secretary, also reporting to Mark Thierer. He replaces Jonathan Friedman who resigned from the company.

$AGN {{ '2017-10-12T22:44:22+0000' | timeago}} • Announcement

$AGN, which inked a controversial patent deal with Mohawk Tribe, reached a patent litigation settlement on its dry eye treatment drug Restasis with InnoPharma, a unit of $PFE. The litigation, which was filed in Sept. 2015 by Allergan, will be withdrawn and Allergan will grant license to InnoPharma to market Restasis from Feb. 2024 or earlier.

$HRC {{ '2017-10-11T12:47:11+0000' | timeago}} • Announcement

$HRC provided an update on its Aspen Surgical facility in Las Piedras, Puerto Rico, where the company manufactures Bard-Parker surgical scalpels and blades. The company confirmed that the facility sustained minor structural damage, temporary loss of power and minimal water damage due to Hurricane Maria.

$AGN {{ '2017-10-10T18:02:39+0000' | timeago}} • Announcement

FDA accepts to review $AGN's New Drug Application seeking approval for ulipristal acetate, an investigational drug for the treatment of abnormal bleeding in women with uterine fibroids. Allergan expects the action date to occur in 1H18. According to the Agency for Healthcare Research and Quality (AHRQ), 26MM women in U.S. have got uterine fibroids.

$VIVO {{ '2017-10-10T16:19:48+0000' | timeago}} • Announcement

$VIVO has appointed John P. Kenny as CEO, effective October 9, 2017. He has also been appointed to $VIVO’s BoD effective October 9, 2017. Mr. Kenny comes to $VIVO from Siemens Healthcare. Concurrent with the hiring of Mr. Kenny, John A. Kraeutler, CEO & Chairman of the Board, steps down as CEO and takes the title of Executive Chairman.

$VRX {{ '2017-10-10T14:50:38+0000' | timeago}} • Infographic

$VRX's progress towards paying down a huge debt of $5Bil before Feb 2018.

$HRC {{ '2017-10-10T14:13:09+0000' | timeago}} • Announcement

$HRC's Welch Allyn subsidiary said its home medical devices will now be offered as part of $HON’s remote patient monitoring platform. The Welch Allyn Home 1700 Series Blood Pressure Monitor and Welch Allyn Home Weight Scale will be offered as standard peripherals with Honeywell Life Care Solution's Genesis Touch remote patient monitoring kits.

$AMGN {{ '2017-10-05T21:56:58+0000' | timeago}} • Announcement

$AMGN said first randomized study to evaluate Imlygic (talimogene laherparepvec), an oncolytic viral therapy, in combination with a checkpoint inhibitor published in the Journal of Clinical Oncology. The study met its primary endpoint of objective response rate. Imlygic is designed to rupture cancer cells causing release of tumor-derived antigens.

$REGN {{ '2017-10-05T17:28:07+0000' | timeago}} • Announcement

Sanofi and $REGN said the U.S. Court of Appeals for the Federal Circuit has ordered new trial and vacated permanent injunction in the dispute concerning $AMGN's asserted patent claims for antibodies targeting PCSK9. This ruling means that Sanofi and $REGN will continue marketing, selling and manufacturing Praluent (alirocumab) injection in the U.S.

Recent Transcripts

UNH (UnitedHealth Group Incorporated)
Tuesday, October 17 2017 - 12:45pm
NEOG (Neogen Corp.)
Tuesday, September 19 2017 - 3:00pm
IMMU (Immunomedics Inc.)
Wednesday, August 16 2017 - 9:00pm
VRML (Vermillion, Inc.)
Wednesday, August 9 2017 - 8:30pm
XRAY (DENTSPLY International Inc.)
Wednesday, August 9 2017 - 12:30pm
NAVB (Navidea Biopharmaceuticals, Inc)
Wednesday, August 9 2017 - 12:00pm
MYGN (Myriad Genetics, Inc.)
Tuesday, August 8 2017 - 8:30pm
NVAX (Novavax, Inc.)
Tuesday, August 8 2017 - 8:30pm
QTNT (Quotient Limited)
Tuesday, August 8 2017 - 12:30pm
ENDP (Endo International plc)
Tuesday, August 8 2017 - 12:30pm
VRX (Valeant Pharmaceuticals International, Inc.)
Tuesday, August 8 2017 - 12:00pm
AGN (Allergan plc)
Thursday, August 3 2017 - 12:30pm
MASI (Masimo Corporation)
Wednesday, August 2 2017 - 8:30pm
TRXC (TransEnterix, Inc.)
Wednesday, August 2 2017 - 8:30pm
KTWO (K2M Group Holdings, Inc.)
Tuesday, August 1 2017 - 9:00pm
ILMN (Illumina Inc.)
Tuesday, August 1 2017 - 8:30pm
IDXX (IDEXX Laboratories, Inc.)
Tuesday, August 1 2017 - 12:30pm
OXFD (Oxford Immunotec Global PLC)
Tuesday, August 1 2017 - 12:00pm
ABBV (AbbVie Inc.)
Friday, July 28 2017 - 1:00pm
HRC (Hill-Rom Holdings, Inc.)
Friday, July 28 2017 - 12:30pm

AlphaGraphics you may like